Jeremy Schreiber,

MSN, PMHNP-BC

Jeremy Schreiber

MSN, PMHNP-BC

Founder, CEO, and Psychiatric-Mental Health Nurse Practitioner Prescriber, Enlighten Health Care

Jeremy Schreiber,

MSN, PMHNP-BC

Founder, CEO, and Psychiatric-Mental Health Nurse Practitioner Prescriber, Enlighten Health Care

Jeremy Schreiber is a healthcare professional with a strong focus on mental health. Currently serving as adjunct faculty for West Liberty University in West Liberty, West Virginia, Jeremy is also a clinical preceptor for numerous educational institutions across the nation. Dedicated to the advancement of mental health care, he obtained his Master of Science in Nursing degree from Ohio State University, and he is a current member of the Mental Health Working Group for the Alliance for Patient Access and the TD Expert Panel for the CureSZ foundation. Jeremy is the Founder and CEO of Enlighten Health Care, LLC, a leading healthcare organization based in Wheeling, West Virginia, where he actively practices as a Psychiatric-Mental Health Nurse Practitioner.

Jeremy's Shared Resources

Instructional Video Highlights the Importance of AIMS Exam for Detecting and Monitoring Tardive Dyskinesia

In this instructional video, Dr. Rakesh Jain, co-chair of Psych Congress, emphasizes the importance of the Abnormal Involuntary Movement Scale...
Picture of Jeremy Schreiber,

Jeremy Schreiber,

MSN, PMHNP-BC
Founder, CEO, and Psychiatric-Mental Health Nurse Practitioner Prescriber, Enlighten Health Care
CURATED BY:
Jennifer A. Sampang,
PhD, MSN, APRN, PMHNP-BC
Read More >

Deutetrabenazine Proven Effective and Safe for Long-Term Tardive Dyskinesia Management

Tardive dyskinesia (TD), often associated with dopamine receptor antagonist (DRA) use, affects individuals with psychotic or mood disorders. This study...
Picture of Jeremy Schreiber,

Jeremy Schreiber,

MSN, PMHNP-BC
Founder, CEO, and Psychiatric-Mental Health Nurse Practitioner Prescriber, Enlighten Health Care
CURATED BY:
Jeremy Schreiber,
MSN, PMHNP-BC
Read More >

Understanding the Differences Between Tardive Dyskinesia and Other Movement Disorders

Tardive dyskinesia (TD) is an involuntary movement disorder that develops as a side effect of long-term use of medications that...
Picture of Jeremy Schreiber,

Jeremy Schreiber,

MSN, PMHNP-BC
Founder, CEO, and Psychiatric-Mental Health Nurse Practitioner Prescriber, Enlighten Health Care
CURATED BY:
Jeremy Schreiber,
MSN, PMHNP-BC
Read More >

Early Diagnosis and Treatment Essential for Managing Tardive Dyskinesia and Minimizing Risks

Tardive dyskinesia (TD) is a movement disorder caused by long-term use of dopamine receptor-blocking agents, especially antipsychotics....
Picture of Jeremy Schreiber,

Jeremy Schreiber,

MSN, PMHNP-BC
Founder, CEO, and Psychiatric-Mental Health Nurse Practitioner Prescriber, Enlighten Health Care
CURATED BY:
Jeremy Schreiber,
MSN, PMHNP-BC
Read More >

Experts Discuss Managing Co-Occurring Drug-Induced Parkinsonism and Tardive Dyskinesia

In a discussion led by Rakesh Jain, MD, MPH, experts Rajeev Kumar, MD, and Jonathan Meyer, MD, explored the complexities...
Picture of Jeremy Schreiber,

Jeremy Schreiber,

MSN, PMHNP-BC
Founder, CEO, and Psychiatric-Mental Health Nurse Practitioner Prescriber, Enlighten Health Care
CURATED BY:
Jeremy Schreiber,
MSN, PMHNP-BC
Read More >

Experts Develop Impact-TD Scale to Assess Tardive Dyskinesia’s Daily Impact

A consensus panel of nine experts developed the Impact-TD scale to assess how tardive dyskinesia (TD) affects daily functioning. This...
Picture of Jeremy Schreiber,

Jeremy Schreiber,

MSN, PMHNP-BC
Founder, CEO, and Psychiatric-Mental Health Nurse Practitioner Prescriber, Enlighten Health Care
CURATED BY:
Jeremy Schreiber,
MSN, PMHNP-BC
Read More >
Load More

Privacy Policy
Terms of Use

Company
Contact

Partner with Us
Ambassador Program

© 2024 Point of Care Network, LLC. All Rights Reserved.

Privacy Policy Terms of Use Company Contact Partner with Us Ambassador Program

© 2024 Point of Care Network, LLC. All Rights Reserved.

Share